ישראל - עברית - Ministry of Health

novo nordisk ltd., israel - insulin aspart - תרחיף להזרקה - insulin aspart 100 u/ml - insulin aspart - insulin aspart - treatment of diabetes mellitus.

ישראל - עברית - Ministry of Health

sanofi israel ltd - insulin glulisine - תמיסה להזרקה - insulin glulisine 100 u/ml - insulin glulisine - insulin glulisine - treatment of adults, adolescents and children, 6 years or older with diabetes mellitus, where treatment with insulin is required.

ישראל - עברית - Ministry of Health

novo nordisk ltd., israel - insulin (human) - תרחיף להזרקה - insulin (human) 100 iu/ml - insulin (human) - insulin (human) - treatment of diabetes mellitus.

ישראל - עברית - Ministry of Health

novo nordisk ltd., israel - insulin (human) - תרחיף להזרקה - insulin (human) 100 iu/ml - insulin (human) - insulin (human) - treatment of diabetes mellitus.

ישראל - עברית - Ministry of Health

eli lilly israel ltd, israel - insulin (human) - תרחיף להזרקה - insulin (human) 100 iu/ml - insulin (human) - insulin (human) - for the treatment of diabetes.

ישראל - עברית - Ministry of Health

eli lilly israel ltd, israel - insulin (human) - תרחיף להזרקה - insulin (human) 100 iu/ml - insulin (human) - insulin (human) - for the treatment of diabetes.

ישראל - עברית - Ministry of Health

novo nordisk ltd., israel - insulin (human) - תרחיף להזרקה - insulin (human) 100 iu/ml - insulin (human) - insulin (human) - treatment of diabetes mellitus.

ישראל - עברית - Ministry of Health

novo nordisk ltd., israel - insulin (human) - תרחיף להזרקה - insulin (human) 100 iu/ml - insulin (human) - insulin (human) - treatment of diabetes mellitus.

ישראל - עברית - Ministry of Health

novo nordisk ltd., israel - insulin aspart - תרחיף להזרקה - insulin aspart 100 u/ml - insulin aspart - insulin aspart - treatment of diabetes mellitus.

ישראל - עברית - Ministry of Health

astrazeneca (israel) ltd - exenatide - אבקה וממס להכנת תרחיף להזרקה - exenatide 2 mg - exenatide - exenatide - bydureon is indicated for treatment of type 2 diabetes mellitus in combination with : • metformin• sulphonylurea• metformin and sulphonylureain adults who have not achieved adequate glycaemic control on maximally tolerated doses of these oral therapies.